Logo-apb
Adv Pharm Bull. 2025;15(3): 499-505. doi: 10.34172/apb.025.43911
PMID: 41403736        PMCID: PMC12703388

Review Article

Localized Semaglutide Injection for Hyperinsulinemia-Induced Lymphatic Dysfunction: A Narrative Review Proposing a Promising Metabolic Perspective for Lymphedema Therapy

Maher Monir. Akl 1 * ORCID, Amr Ahmed 2 ORCID

Cited by CrossRef:


1- Chen H, Zhao Y, Ge C, Wang J, Wang Z, Wang H, Cheng S, Wang Y, Yang J, Wang D, Chong H, Kong C. Endothelial Dysfunction and Metabolic Reprogramming in Cardiovascular Diseases. Rev Cardiovasc Med. 2026;27(9) [Crossref]
2- Sarma A, Devi M, Kumar D, Choudhary N. Gut microbiota-derived TMA/TMAO and IRAK4 signaling in type 2 diabetes: Current evidence, knowledge gaps and future therapeutic opportunities. International Immunopharmacology. 2026;188:117240 [Crossref]
3- Ye K, Jiang L, Chen J, Yuan S, Xiao T, Chen Y, Xiong T, Luo Z, Deng C, Xiao S. Therapeutic targeting of local metabolic dysfunction in secondary lymphedema: mechanisms and opportunities. Front Physiol. 2026;17 [Crossref]